Filgrastim biosimilar (Biogenomics)

非格司亭生物类似药（Biogenomics）

Report date: 2025/02/19 16:42:48

Base Information

Drug NameFilgrastim biosimilar (Biogenomics)

Drug Alias Name重组人粒细胞刺激因子（Biogenomics）Recombinant human granulocyte macrophage colony stimulating factor (Biogenomics)非格司亭生物仿制药（Biogenomics）rhG-CSF (Biogenomics)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIndia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesBiogenomics

China Registration ClassN/A

Develop Information

Active CompaniesBiogenomics

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02